PMID- 37377923
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230701
IS  - 1663-9812 (Print)
IS  - 1663-9812 (Electronic)
IS  - 1663-9812 (Linking)
VI  - 14
DP  - 2023
TI  - Factors influencing clinical pharmacists' integration into the clinical 
      multidisciplinary care team.
PG  - 1202433
LID - 10.3389/fphar.2023.1202433 [doi]
LID - 1202433
AB  - Objectives: To investigate the factors influencing clinical pharmacists' 
      integration into the clinical multidisciplinary care team, using 
      interprofessional collaboration between clinical pharmacists and physicians as 
      the focus. Methods: Through stratified random sampling, a cross-sectional 
      questionnaire survey was conducted among clinical pharmacists and physicians in 
      secondary and tertiary hospitals in China from July to August 2022. The 
      questionnaire, comprising the Physician-Pharmacist Collaborative Index (PPCI) 
      scale to reflect the collaboration level and a combined scale to measure 
      influencing factors, was made available in two versions for clinical pharmacists 
      and physicians. Multiple linear regression was adopted to analyze the association 
      between the collaboration level and influencing factors, as well as the 
      heterogeneity of the significant factors in hospitals of different grades. 
      Results: Valid self-reported data from 474 clinical pharmacists and 496 paired 
      physicians were included, who were serving in 281 hospitals from 31 provinces. In 
      terms of participant-related factors, standardized training and academic degree, 
      respectively, exerted significant positive effects on the perceived collaboration 
      level by clinical pharmacists and physicians. In terms of context 
      characteristics, manager support and system construction were the main factors 
      for improving collaboration. In terms of exchange characteristics, clinical 
      pharmacists having good communication skills, physicians trusting others' 
      professional competence and values, and both parties having consistent 
      expectations had significant positive effects on collaboration. Conclusion: The 
      study provides a baseline data set on the current level and associated factors of 
      clinical pharmacists' collaboration with other professionals in China and other 
      countries with a related health system, providing references for individuals, 
      universities, hospitals, and national policymakers to facilitate the development 
      of clinical pharmacy and multidisciplinary models and further improve the 
      patient-centered integrated disease treatment system.
CI  - Copyright (c) 2023 Wang, Li, Huang and Xi.
FAU - Wang, Chenyu
AU  - Wang C
AD  - National Medical Products Administration Key Laboratory for Drug Regulatory 
      Innovation and Evaluation, China Pharmaceutical University, Nanjing, China.
FAU - Li, Maozhen
AU  - Li M
AD  - National Medical Products Administration Key Laboratory for Drug Regulatory 
      Innovation and Evaluation, China Pharmaceutical University, Nanjing, China.
FAU - Huang, Yuankai
AU  - Huang Y
AD  - National Medical Products Administration Key Laboratory for Drug Regulatory 
      Innovation and Evaluation, China Pharmaceutical University, Nanjing, China.
FAU - Xi, Xiaoyu
AU  - Xi X
AD  - National Medical Products Administration Key Laboratory for Drug Regulatory 
      Innovation and Evaluation, China Pharmaceutical University, Nanjing, China.
LA  - eng
PT  - Journal Article
DEP - 20230612
PL  - Switzerland
TA  - Front Pharmacol
JT  - Frontiers in pharmacology
JID - 101548923
PMC - PMC10291231
OTO - NOTNLM
OT  - China
OT  - clinical pharmacist
OT  - influencing factors
OT  - interprofessional collaboration
OT  - multidisciplinary care team
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/28 13:09
MHDA- 2023/06/28 13:10
PMCR- 2023/06/12
CRDT- 2023/06/28 09:24
PHST- 2023/04/18 00:00 [received]
PHST- 2023/05/25 00:00 [accepted]
PHST- 2023/06/28 13:10 [medline]
PHST- 2023/06/28 13:09 [pubmed]
PHST- 2023/06/28 09:24 [entrez]
PHST- 2023/06/12 00:00 [pmc-release]
AID - 1202433 [pii]
AID - 10.3389/fphar.2023.1202433 [doi]
PST - epublish
SO  - Front Pharmacol. 2023 Jun 12;14:1202433. doi: 10.3389/fphar.2023.1202433. 
      eCollection 2023.